checkAd

     450  0 Kommentare Apollo Endosurgery Announces DDW 2019 Clinical Highlights - Seite 2

    The pooled analysis included eleven studies (prospective and retrospective) of ESG published between January 2013 and October 2018 and included 477 patients. The pooled TBWL was 16.5% at 6 months. The review identified no serious adverse events or patient mortality.

    ESG for Obesity: Improved Body Composition at 1-Year Follow-Up. AuthorsAdrian Sartoretto2, George Marinos2, Zhixian Sui.1,2 1The University of New South Wales, Randwick, New South Wales, Australia, 2The BMI Clinic, Double Bay, New South Wales, Australia.

    This study analyzed 121 consecutive patients who underwent ESG in an outpatient setting from October 2016 to January 2018. At one year, the average TBWL was 17% and 80% of patients had lost more than 10%. Unique to this study was the evaluation of body composition. On average, there was a reduction in body fat mass of 15.7 kg, and an increase in lean body mass of 3.5 kg, and a reduction in visceral fat mass of 1.4 kg. The authors suggested that the increase in lean body mass and improved body composition lowers the risk of weight regain following an ESG. The authors also reported that there were no major intra or post procedure complications.

    Safety and Efficacy of ESG for Obesity Management in New Bariatric Endoscopy Programs: A Multicenter International Study. Authors: Avik Sarkar1, Augustine Tawadros1, Iman Andalib1, Haroon M. Shahid1, Amy Tyberg1, Resheed Alkhiari1, Monica Gaidhane1, Prashant Kedia2, Keshav Kukreja2, Elizabeth S. John2, Bryce Bushe2, Ma Guadalupe Martínez4, Felipe Zamarripa4, Mine C. Carames5, Juan C. Carames5, Fernando Casasrodriguez6, Vincenzo Bove3, Guido Costamagna3, Ivo Boskoski3, Michel Kahaleh.1 1Gastroenterology, Robert Wood Johnson, New Brunswick, New Jersey, United States; 2Gastroenterology, Methodist Hospital, Dallas, Texas, United States; 3Gastroenterology, Fondazione Policlinico A. Gemelli, Roma, Italy; 4Gastroenterology, Hospital Juarez de Mexico, Mexico City, Mexico; 5Gastroenterology, Santander Hospital, Reynosa, Mexico; 6Gastroenterology, Hospital Central de la Policia, Bogota, Colombia.

    This was an international, multicenter, retrospective study reviewing the outcomes of ESG in centers starting an ESG program. The study reported technical success in 100% of the patients in all six centers, a mean procedure time of 89 minutes, and no significant adverse events. These results demonstrated equivalence in outcomes for new ESG centers as compared to previous studies by experienced ESG centers.

    Seite 2 von 4



    Business Wire (engl.)
    0 Follower
    Autor folgen

    Apollo Endosurgery Announces DDW 2019 Clinical Highlights - Seite 2 Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced highlights from DDW 2019 which took place from May 18th to May 21st in …